Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
Isoniazid resistant Mycobacterium tuberculosis (Hr-TB) is the most frequently encountered TB resistance phenotype in North America but limited data exist on the effectiveness of current therapeutic regimens. Ineffective treatment of Hr-TB increases patient relapse and anti-mycobacterial resistance,...
Main Authors: | Brett D Edwards, Jenny Edwards, Ryan Cooper, Dennis Kunimoto, Ranjani Somayaji, Dina Fisher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229691 |
Similar Items
-
Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.
by: Brett D Edwards, et al.
Published: (2021-01-01) -
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007
by: Deanne Langlois-Klassen, et al.
Published: (2013-05-01) -
Lymphocutaneous spread of in an immunocompetent individual: A case report
by: Brett D Edwards, et al.
Published: (2021-07-01) -
Isoniazid resistance in Mycobacterium tuberculosis
by: Tho, Dau Quang
Published: (2012) -
Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)